WANBURY

Wanbury Share PriceWanbury

₹39.95
0.65 (1.65%)
As on 26 March, 2023 | 16:45 BSE: 524212 NSE: WANBURY

Wanbury Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Wanbury

Start SIP

Wanbury Share Price

  • Over 1 Month 4.58%
  • Over 3 Month -8.58%
  • Over 6 Month -39.24%
  • Over 1 Year -53.55%

Wanbury Key Statistics

P/E Ratio 1.8
PEG Ratio 0
Market Cap Cr 131
Price to Book Ratio -5.6
EPS 1.7
Dividend 0
Relative Strength Index 57.33
Money Flow Index 60.78
MACD Signal -1.41
Average True Range 2.04

Wanbury Investment Rating

  • Master Rating:
  • Wanbury has an operating revenue of Rs. 501.07 Cr. on a trailing 12-month basis. An annual revenue growth of 30% is outstanding, Pre-tax margin of 16% is great, ROE of -347% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 10 which is a POOR score indicating inconsistency in earnings, a RS Rating of 12 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 80 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Wanbury Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 126124117134
Operating Expenses Qtr Cr 119118120122
Operating Profit Qtr Cr 66-313
Depreciation Qtr Cr 3333
Interest Qtr Cr 7435
Tax Qtr Cr 000-1
Net Profit Qtr Cr -3-1-783

Wanbury Technicals

EMA & SMA

Current Price
₹39.95
0.65 (1.65%)
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • 37.63
  • 50 Day
  • 40.44
  • 100 Day
  • 45.69
  • 200 Day
  • 53.73
  • 20 Day
  • 37.08
  • 50 Day
  • 40.21
  • 100 Day
  • 45.91
  • 200 Day
  • 55.49

Wanbury Resistance and Support

PIVOT
₹38.94
Resistance
First Resistance 39.67
Second Resistance 40.04
Third Resistance 40.77
RSI 57.33
MFI 60.78
MACD Single Line -1.41
MACD -0.8
Support
First Resistance 38.57
Second Resistance 37.84
Third Resistance 37.47

Wanbury Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 131,439 13,143,900 100
Week 88,404 8,840,440 100
1 Month 48,964 4,896,386 100
6 Month 28,860 2,886,031 100

Wanbury Result Highlights

Wanbury Synopsis

NSE-Medical-Generic Drugs

Wanbury is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 511.19 Cr. and Equity Capital is Rs. 32.67 Cr. for the Year ended 31/03/2022. Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455.
Market Cap 131
Sales 501
Shares in Float 1.96
No of funds 5
Yield
Book Value 59.63
U/D Vol ratio 1.3
LTDebt / Equity
Alpha -0.28
Beta 0.4

Wanbury

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 39.84%39.85%39.85%
Mutual Funds
Foreign Portfolio Investors
Financial Institutions/ Banks
Individual Investors 38.11%38.67%38.42%
Others 22.05%21.48%21.73%

Wanbury Management

Name Designation
Mr. K Chandran Vice Chairman & Whole Time Dir
Mr. N K Puri Ind. Non-Executive Director
Mr. S K Bhattacharya Ind. Non-Executive Director
Ms. Pallavi P Shedge Ind. Non-Executive Director
Mr. Binod Chandra Maharana Ind. Non-Executive Director
Dr. Manisha Juvekar Ind. Non-Executive Director

Wanbury Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Wanbury FAQs

What is Share Price of Wanbury ?

Wanbury share price is ₹39 As on 26 March, 2023 | 16:31

What is the Market Cap of Wanbury ?

The Market Cap of Wanbury is ₹130.7 Cr As on 26 March, 2023 | 16:31

What is the P/E ratio of Wanbury ?

The P/E ratio of Wanbury is 1.8 As on 26 March, 2023 | 16:31

What is the PB ratio of Wanbury ?

The PB ratio of Wanbury is -5.6 As on 26 March, 2023 | 16:31

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number